Rapid Micro Biosystems Inc (NASDAQ:RPID) has a beta value of 1.31 and has seen 0.39 million shares traded in the recent trading session. The company, currently valued at $166.54M, closed the recent trade at $3.87 per share which meant it gained $0.39 on the day or 11.21% during that session. The RPID stock price is 3.1% off its 52-week high price of $3.75 and 85.01% above the 52-week low of $0.58. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.7 million shares traded. The 3-month trading volume is 223.74K shares.
The consensus among analysts is that Rapid Micro Biosystems Inc (RPID) is Hold stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 1 out of 1 have rated it as a Hold, with 0 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.22.
Rapid Micro Biosystems Inc (NASDAQ:RPID) trade information
Sporting 11.21% in the green today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the RPID stock price touched $3.87 or saw a rise of 3.25%. Year-to-date, Rapid Micro Biosystems Inc shares have moved 330.00%, while the 5-day performance has seen it change 37.23%. Over the past 30 days, the shares of Rapid Micro Biosystems Inc (NASDAQ:RPID) have changed 222.50%. Short interest in the company has seen 0.13 million shares shorted with days to cover at 0.55.
Wall Street analysts have a consensus price target for the stock at $8, which means that the shares’ value could jump 51.62% from the levels at last check today. The projected low price target is $8.0 while the price target rests at a high of $8.0. In that case, then, we find that the latest price level in today’s session is -106.72% off the targeted high while a plunge would see the stock gain -106.72% from the levels at last check today.
Rapid Micro Biosystems Inc (RPID) estimates and forecasts
Figures show that Rapid Micro Biosystems Inc shares have underperformed across the wider relevant industry. The company’s shares have gained 365.93% over the past 6 months, with this year growth rate of 9.84%, compared to 15.40% for the industry. Revenue growth from the last financial year stood is estimated to be 24.78%.
1 analysts offering their estimates for the company have set an average revenue estimate of 8.2M for the current quarter. 2 have an estimated revenue figure of 6.6M for the next ending quarter. Year-ago sales stood 6.34M and 5.61M respectively for this quarter and the next, and analysts expect sales will grow by 29.40% for the current quarter and 24.78% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -16.10% over the past 5 years. Earnings growth for 2025 is a modest 11.20% while over the next 5 years, the company’s earnings are expected to increase by 12.40%.
RPID Dividends
Rapid Micro Biosystems Inc is expected to release its next earnings report in March this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Rapid Micro Biosystems Inc (NASDAQ:RPID)’s Major holders
Insiders own 8.14% of the company shares, while shares held by institutions stand at 55.88% with a share float percentage of 60.83%. Investors are also buoyed by the number of investors in a company, with Rapid Micro Biosystems Inc having a total of 24.0 institutions that hold shares in the company. The top two institutional holders are BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC with over 8.43 million shares worth more than $5.57 million. As of 2024-06-30, BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC held 19.5038% of shares outstanding.
The other major institutional holder is KENNEDY LEWIS MANAGEMENT LP, with the holding of over 4.94 million shares as of 2024-06-30. The firm’s total holdings are worth over $3.26 million and represent 11.4229% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and BlackRock Health Sciences Term Trust. As of Sep 30, 2024, the former fund manager holds about 1.58% shares in the company for having 594.57 shares of worth $2.25 million while later fund manager owns 571.18 shares of worth $2.16 million as of Sep 30, 2024, which makes it owner of about 1.51% of company’s outstanding stock.
